Accessibility Menu
BioRem logo

BioRem(OTC) BIRMF

Market Cap$42.56MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2012)+1,640%
5 Year+604%
1 Year+74%
1 Month+20%
$2.61
-7.12%
-0.20Today
BioRem last closing stock price
MetricPriceDate
Last closeUSD 2.612026-08-05
BioRem stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+4.82%USD 2.492026-07-29
1 month+20.28%USD 2.172026-07-06
3 month+4.4%USD 2.502026-05-07
Year to date+31.16%USD 1.992025-12-30
1 year+74%USD 1.502025-08-05
3 year+289.55%USD 0.672023-06-12
5 year+604.26%USD 0.372021-08-05
Since inception+1,640%USD 0.152012-12-11

BioRem Financials at a Glance

Market Cap

$42.56MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CA$50.70M

Net Income (TTM)

CA$6.22M

EPS (TTM)

$0.24

P/E Ratio

9.40

Dividend

$0.00

Beta (Volatility)

-91.30 (Low)

Price

$2.61

Volume

10

Open

$2.61

Previous Close

$2.61

Daily Range

$2.61 - $2.61

52-Week Range

$1.34 - $2.86

Estimated Earnings Date

Aug 24, 2026

BIRMF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About BioRem

BioRem Inc. is an engineering firm specializing in clean technology, focusing on advanced air purification systems. The company effectively eliminates unpleasant odors, volatile organic compounds (VOCs), and hazardous air pollutants (HAPs) through innovative solutions.

Products and Services
  • Biofilters targeting odors, H2S, VOCs, and HAPs
  • Biotrickling filters for high concentrations of H2S
  • Multi-stage systems for municipal wastewater treatment
Growth Outlook
  • Revenue increased to CAD 15.69 million in Q2 2026
  • Net income rose to CAD 1.98 million in Q2 2026
  • Operating income margin improved to 17.17% in Q2 2026
Financial Highlights
  • Trailing twelve months (TTM) P/E ratio of 8.95 indicates strong valuation
  • Net profit margin of 12.26% reflects effective cost management
  • Current ratio of 2.04 suggests strong liquidity position
BioRem Inc. has established itself as a leader in the clean technology sector, providing essential solutions for air purification. The company's diverse product offerings cater to various industries, including municipal wastewater treatment and cannabis odor mitigation. Recent financial performance highlights a significant increase in revenue and net income, showcasing the company's growth trajectory. The strong operating income margin and favorable liquidity position further enhance its appeal to potential investors. With a solid foundation and a commitment to innovation, BioRem Inc. is well-positioned for continued success in the clean technology market.
AI Generated • Aug 3, 2026

Industry

Commercial Services and Supplies

Sector

Industrials

CEO

Derek S. Webb, MBA

Website

www.biorem.biz

Headquarters

Puslinch, ON N0B 2J0, CA

BIRMF Financials

Key Financial Metrics (TTM)

Gross Margin

30.40%

Operating Margin

16.45%

Net Income Margin

12.26%

Return on Equity

41.45%

Return on Capital

37.02%

Return on Assets

17.44%

Earnings Yield

10.64%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$42.56MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

16.31M

Volume

10

Avg. Volume

3.43K

Financials (TTM)

Gross Profit

CA$15.41M

Operating Income

CA$8.34M

EBITDA

CA$8.79M

Operating Cash Flow

CA$322.76K

Capital Expenditure

-CA$319.42K

Free Cash Flow

CA$3.34K

Cash & ST Invst.

CA$7.19M

Total Debt

CA$2.49M

BioRem Performance Analysis

BioRem annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31CAD 22,170,67613.6%
20232023-12-31CAD 18,645,396-15.9%
20242024-12-31CAD 27,313,87546.5%
20252025-12-31CAD 30,312,52911.0%
BioRem sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-3019.3%
Q42025-12-3150.4%
Q12026-03-31-59.6%
Q22026-06-30129.6%
BioRem annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31CAD 0.07154.9%
20232023-12-31CAD 0.0933.7%
20242024-12-31CAD 0.1225.7%
20252025-12-31CAD 0.1855.8%
BioRem sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-3055.5%
Q42025-12-31141.2%
Q12026-03-31-92.7%
Q22026-06-30900.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

CA$15.69M

+66.4%

Gross Profit

CA$4.91M

+92.6%

Gross Margin

31.31%

N/A

Market Cap

$42.56MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$1.25M

N/A

Employees

34

N/A

Net Income

CA$1.98M

+166.1%

EBITDA

CA$2.83M

+143.3%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

CA$7.19M

-6.1%

Total Debt

CA$2.49M

-20.6%

Accounts Receivable

CA$19.14M

+57.1%

Inventory

CA$2.13M

+17.9%

Long Term Debt

CA$1.79M

-27.5%

Short Term Debt

CA$698.80K

+4.8%

Return on Assets

17.44%

N/A

Return on Invested Capital

43.03%

N/A

Free Cash Flow

-CA$2.84M

-79.2%

Operating Cash Flow

-CA$2.82M

-111.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
MRCRMoro Corporation
$5.33+0.00%
AUSIAura Systems, Inc.
$0.17+0.00%
GRNWFGreenlane Renewables Inc.
$0.14+0.00%
TMGEFThermal Energy International Inc.
$0.12+11.55%

Trending Stocks

Symbol / CompanyPricePrice Chg
SPCXSpace Exploration Technologies
$138.74+0.04%
ACHRArcher Aviation
$6.26+0.12%
NVDANvidia
$217.55-0.03%
INTCIntel
$97.52-0.04%

Questions About BIRMF

What is the current price of BioRem?

BioRem is trading at $2.61 per share.

What is the 52-week range for BioRem?

Over the past 52 weeks, BioRem has traded between $1.34 and $2.86.

How much debt does BioRem have?

As of the most recent reporting period, BioRem reported total debt of CA$1.76M.

How much cash does BioRem have on hand?

BioRem reported CA$5.07M in cash and cash equivalents in its most recent financial results.

What is BioRem’s dividend yield?

BioRem does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services